MYC and metabolic dysfunction-associated steatotic liver disease: c-Myc expression appears to occur later than P2-HNF4α and p-STAT3 because: 1, it is only seen in a subset of the patients positive for p-STAT3 (except one patient); 2, it is significantly associated with advanced fibrosis which is known to occur at the end stage in NAFLD progression; and 3, because cases that are positive for all three markers are more likely to be associated with advanced fibrosis.